{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:39:52Z","timestamp":1773290392111,"version":"3.50.1"},"reference-count":29,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2004,10,8]],"date-time":"2004-10-08T00:00:00Z","timestamp":1097193600000},"content-version":"vor","delay-in-days":4878,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Neurology"],"published-print":{"date-parts":[[1991,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Parkinson's disease is thought ot cause degeneration of melanin\u2010pigmented catecholaminergic neurons throughout the brainstem, but little quantitative information is available on the fate of catecholaminergic neurons associated with the dorsal vagal complex or medullary reticular formation. We therefore examined these neurons in the normal human medulla and in the brains of patients with Parkinson's disease, using both a melanin stain and immunohistochemical methods with an antiserum against tyrosine hydroxylase. The greatest numbers of catecholaminergic neurons in the ventrolateral reticular formation (A1\/C1 group) were located in the far rostral medulla, whereas the largest populations of catecholaminergic cells in the dorsal vagal complex (A2\/C2 group) were found at the level of the area postrema. No loss of cells was observed in the A1\/C1 group in the parkinsonian brains. In contrast, the A2\/C2 group showed moderate loss of neurons, most marked at the level of the area postrema. This difference was entirely due to the loss of neurons in the medial component of the A2 group, a population that normally is only lightly pigmented, while the heavily pigmented neurons in the ventral and intermediate components of the A2 complex were unaffected. Parkinson's disease causes degeneration only of selected populations of medullary catecholaminergic neurons, without apparent relationship to the extent of melanin pigmentation.<\/jats:p>","DOI":"10.1002\/ana.410290602","type":"journal-article","created":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T12:01:19Z","timestamp":1104580879000},"page":"577-584","source":"Crossref","is-referenced-by-count":73,"title":["Medullary catecholaminergic neurons in the normal human brain and in Parkinson's disease"],"prefix":"10.1002","volume":"29","author":[{"given":"Clifford B.","family":"Saper","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise M.","family":"Sorrentino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dwight C.","family":"German","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonsoles De","family":"Lacalle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,10,8]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"121","article-title":"Neuromelanin and Parkinson's disease","volume":"19","author":"Marsden CD","year":"1984","journal-title":"J Neural Transm"},{"key":"e_1_2_1_3_2","first-page":"109","volume-title":"Parkinson's disease. Current progress, problems and management. Proceedings of the North European Symposium on Parkinson's Disease","author":"Hornykiewicz O","year":"1980"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00696560"},{"key":"e_1_2_1_5_2","first-page":"359","article-title":"On the origin and significance of neuromelanin","volume":"103","author":"Graham DG","year":"1979","journal-title":"Arch Pathol Lab Med"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/334345a0"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.36.2.250"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410180507"},{"key":"e_1_2_1_9_2","first-page":"387","article-title":"Zur pathologie der paralysis agitans und des postencephalitischen Parkinsonismus","volume":"48","author":"Hassler R","year":"1938","journal-title":"J Psychol Neurol"},{"key":"e_1_2_1_10_2","first-page":"516","volume-title":"Anatomie cerebrale. Les noyaux gris centraux et la region mesencephalosousoptique. Suivi d'un appendice sur l'anatomie de la maladie Parkinson","author":"Foix C","year":"1925"},{"key":"e_1_2_1_11_2","first-page":"1152","volume-title":"Pathology of the nervous system","author":"Alvord EC","year":"1968"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.17.5.512"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/cne.901970106"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/105.1.87"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(83)90023-4"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/cne.902730207"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/cne.902730303"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410270405"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410260403"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(85)91324-1"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00430868"},{"key":"e_1_2_1_22_2","first-page":"1","article-title":"Evidence for the existence of monoamine\u2010containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons","volume":"232","author":"Dahlstrom A","year":"1964","journal-title":"Acta Physiol Scand Suppl"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(74)90143-7"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/cne.902120207"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/cne.902590408"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(88)90009-7"},{"key":"e_1_2_1_27_2","first-page":"1","article-title":"Overview of morphological changes in Parkinson's disease","volume":"45","author":"Jellinger K","year":"1986","journal-title":"Adv Neurol"},{"key":"e_1_2_1_28_2","first-page":"149","article-title":"Autonomic disorders in idiopathic Parkinsonism","volume":"22","author":"Martignoni E","year":"1986","journal-title":"J Neural Transm"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(80)90571-5"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(84)90191-5"}],"container-title":["Annals of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fana.410290602","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ana.410290602","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T00:49:06Z","timestamp":1698022146000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ana.410290602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,6]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1991,6]]}},"alternative-id":["10.1002\/ana.410290602"],"URL":"https:\/\/doi.org\/10.1002\/ana.410290602","archive":["Portico"],"relation":{},"ISSN":["0364-5134","1531-8249"],"issn-type":[{"value":"0364-5134","type":"print"},{"value":"1531-8249","type":"electronic"}],"subject":[],"published":{"date-parts":[[1991,6]]}}}